Mutia, Fernanda .

HRN: 20-20-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/18/2026
03/25/2026
IV
600MG
Q6H
SACRAL ULCER
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: